With Greater Liquidity Comes Greater Private Asset Valuation Frequency
The new buzz phrase—”monthly valuation”—is taxing internal valuation teams and redefining relationships between fund sponsors and valuation providers.
Why VRC for Portfolio Valuation?
Learn why eminent private fund managers and their boards rely on our team.
A 2Q Update on Middle Market Credit Spreads and Required Returns
Considering competitive market dynamics, market participants report a tightening in credit spreads since Q2 2020 and generally stable credit spreads in 2Q21.
Resource Guide to Navigating SEC Rule 2A-5
VRC’s Rule 2a-5 Resource Guide provides the details fund managers and fund boards need to come into compliance with the SEC’s new regulations to fair value portfolio securities.
SEC to SPACs: Blank-Check Path to IPO, Warrants, Disclosures Have Liability Risk
The SEC has been clear. They will continue to keep a close watch on SPAC filings and disclosures and their private targets.
How Fairness Opinions Help Private Equity Sponsors Head Off Family Feuds
Related-party transactions between PE funds and their portfolio companies are fraught with the potential to create issues between limited partners. Fairness opinions can forestall such conflicts.
Best Practices for Private Fund Sponsors
As the demand for transparency rises for private investment funds, the spotlight is on valuation practices, which is essential for any fund manager to understand.
Q1 2021: Middle Market Credit Spreads and Required Returns
How are market participants reacting to positive vaccination rates, economic optimism, company prospects and floating rate security demand?
Birnbaum, Walling on Valuing Private Energy Debt and Equity in Private Funds CFO
As seen in the newest issue of Private Funds CFO, Jeff Birnbaum and Chris Walling discuss the implications of the pandemic for the sector.
Middle Market Credit Spreads and Required Returns
In Q4 2020, market participants noted improving comfort with company and industry fundamentals, outlooks, and the ability to weather a second wave of the virus.